Benzonatate
- Product NDC
- 82982-023
- 11-digit product format
- 829820023
- Labeler code
- 82982
- Product ID
- 82982-023_efe6b6f2-c90f-f440-e053-2a95a90a90fc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Benzonatate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Pharmasource Meds, LLC
- Application
- ANDA202765
- Marketing category
- ANDA
- Marketing start
- 2023-01-09
- Marketing end
- 0000-00-00
- Substance
- BENZONATATE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2024-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 82982-023-30 | 82982002330 | 30 CAPSULE in 1 BOTTLE (82982-023-30) | 30 capsule | 2023-01-09 | 0000-00-00 | No | No | Current |